Updated resource: unpicking the COVID-19 extremely vulnerable category for people affected by cancer

Latest from the Blog

Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Related Posts

World Cancer Day 2021

World Cancer Day 2021

4th February 2021 The 4th of February 2021 marks World Cancer Day 2021. This year, the theme #IAmAndIWill encourages us to recognise our own commitments to improving cancer outcomes. GatewayC now has over 19 free online cancer education courses which can help primary...

read more

Wednesday 15th April 2020

People with certain cancers and those who have received or are receiving certain treatments are at risk of severe illness if they catch coronavirus (COVID-19). One Cancer Voice charities (in partnership with NHS England) have confirmed this includes:

  • Every patient undergoing active chemotherapy
  • Patients who have received chemotherapy in the last three months (advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
  • Patients with blood disorders who are immunocompromised but not receiving chemotherapy
  • Patients having radiotherapy for metastatic lung tumours
  • Patients with metastatic cancer in the lungs who are not currently receiving treatment (if they have not received a letter, advise patients to contact their care team to discuss their specific circumstances. In the meantime, patients should follow the Public Health England guidance on ‘shielding’ – in summary, stay at home and avoid face-to-face contact for a period of 12 weeks)
  • Patients having any targeted treatments (more than just antibody treatments) and anti-angiogenesis targeted drugs
  • Transplant patients (if they have had a transplant within the last 6 months, and if they are taking any immunosuppression)
  • Patients with a rare disease and that disease significantly increases their risk of infection

Find out more:

LinkedIn | Twitter | Facebook

Latest from the Blog

Assessing peripheral neuropathy

Assessing peripheral neuropathy

Thursday 18th February 2021 It is important for primary care practitioners to explore and assess peripheral neuropathy carefully by evaluating the level of impact on the patient, both physically and emotionally. Many individuals receiving chemotherapy are nervous...

read more

Related Posts

World Cancer Day 2021

World Cancer Day 2021

4th February 2021 The 4th of February 2021 marks World Cancer Day 2021. This year, the theme #IAmAndIWill encourages us to recognise our own commitments to improving cancer outcomes. GatewayC now has over 19 free online cancer education courses which can help primary...

read more